• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝肾综合征合并肝硬化心肌病:病例报告及文献综述

Hepatorenal syndrome with cirrhotic cardiomyopathy: case report and literature review.

作者信息

Mocarzel Luis, Lanzieri Pedro, Nascimento Juliana, Peixoto Clara, Ribeiro Mário, Mesquita Evandro

机构信息

Department of Internal Medicine, Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Rua Marquês de Paraná 303, 7° Andar, Centro, 24033-900 Niterói, RJ, Brazil.

Department of Echocardiography, Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Rua Marquês de Paraná 303, 7° Andar, Centro, 24033-900 Niterói, RJ, Brazil.

出版信息

Case Reports Hepatol. 2015;2015:573513. doi: 10.1155/2015/573513. Epub 2015 Mar 22.

DOI:10.1155/2015/573513
PMID:25874140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4385646/
Abstract

The hepatorenal syndrome (HRS) is defined as a potentially reversible kidney failure in patients with cirrhosis and ascites. An association of HRS and cirrhotic cardiomyopathy has been reported recently, but there are no result studies about the use of positive inotropes as part of the acute phase treatment. We report the case of a patient diagnosed with HRS, with high levels of NT pro-BNP, but with normal ejection fraction of the left ventricle, which showed abnormalities in systolic function through speckle tracking in echocardiography, reversible after the infusion of dobutamine. The patient showed clinical and laboratory improvement of his renal function after the infusion of dobutamine. Clinical studies are needed on HRS therapeutic approach taking into account the myocardial dysfunction as a major contributing factor to renal dysfunction.

摘要

肝肾综合征(HRS)被定义为肝硬化和腹水患者中潜在可逆的肾衰竭。最近有报道称HRS与肝硬化性心肌病有关,但尚无关于使用正性肌力药物作为急性期治疗一部分的研究结果。我们报告了一例被诊断为HRS的患者,其NT-proBNP水平升高,但左心室射血分数正常,经超声心动图斑点追踪显示其收缩功能异常,在输注多巴酚丁胺后可逆。该患者在输注多巴酚丁胺后肾功能在临床和实验室检查方面均有改善。需要针对HRS的治疗方法开展临床研究,将心肌功能障碍视为导致肾功能障碍的主要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda5/4385646/5fa8bda9c1fc/CRIHEP2015-573513.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda5/4385646/5fa8bda9c1fc/CRIHEP2015-573513.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda5/4385646/5fa8bda9c1fc/CRIHEP2015-573513.001.jpg

相似文献

1
Hepatorenal syndrome with cirrhotic cardiomyopathy: case report and literature review.肝肾综合征合并肝硬化心肌病:病例报告及文献综述
Case Reports Hepatol. 2015;2015:573513. doi: 10.1155/2015/573513. Epub 2015 Mar 22.
2
Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome.肝硬化心肌病:成功治疗肝肾综合征的又一病例
Case Rep Gastroenterol. 2016 Oct 10;10(3):531-537. doi: 10.1159/000448885. eCollection 2016 Sep-Dec.
3
A Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome.肝硬化心肌病的患病率、预测因素及其在肝肾综合征发生中的作用的前瞻性研究。
J Clin Exp Hepatol. 2022 May-Jun;12(3):853-860. doi: 10.1016/j.jceh.2021.11.005. Epub 2021 Nov 15.
4
LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.超声心动图评估肝硬化患者左心室功能:与全身血液动力学和肾功能障碍的关系。
J Hepatol. 2013 Jan;58(1):51-7. doi: 10.1016/j.jhep.2012.08.027. Epub 2012 Sep 16.
5
The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites.触发因素很重要——肝硬化腹水患者伴肝肾综合征与特定触发的急性肾损伤的结局。
Liver Int. 2016 Nov;36(11):1649-1656. doi: 10.1111/liv.13160. Epub 2016 Jun 30.
6
The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease.肝脏受损时,心脏也至关重要!肝硬化性心肌病:发病率、比较及其与疾病严重程度的相关性。
Prz Gastroenterol. 2016;11(4):247-256. doi: 10.5114/pg.2016.57962. Epub 2016 Feb 16.
7
Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial.多培沙明可逆转特利加压素的心脏抑制作用,但不能改善肝硬化和腹水患者的肾功能:一项随机对照试验。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G313-G321. doi: 10.1152/ajpgi.00328.2019. Epub 2019 Dec 16.
8
Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.口服α-肾上腺素能激动剂米多君对肝硬化腹水患者肾血流动力学和肾功能的急性影响。
Hepatology. 1998 Oct;28(4):937-43. doi: 10.1002/hep.510280407.
9
Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.
Expert Rev Gastroenterol Hepatol. 2016 Oct;10(10):1153-1161. doi: 10.1080/17474124.2016.1196132. Epub 2016 Jun 16.
10
New Developments in Hepatorenal Syndrome.肝肾综合征的新进展。
Clin Gastroenterol Hepatol. 2018 Feb;16(2):162-177.e1. doi: 10.1016/j.cgh.2017.05.041. Epub 2017 Jun 7.

引用本文的文献

1
Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?肝硬化中的肝心肾综合征:一种新疾病实体的认知?
World J Gastroenterol. 2024 Jan 14;30(2):128-136. doi: 10.3748/wjg.v30.i2.128.
2
Cirrhotic Cardiomyopathy: A New Clinical Phenotype.肝硬化心肌病:一种新的临床表型。
Arq Bras Cardiol. 2017 Jun;108(6):564-568. doi: 10.5935/abc.20170066.
3
Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome.肝硬化心肌病:成功治疗肝肾综合征的又一病例

本文引用的文献

1
Pathophysiological and clinical approach to cirrhotic cardiomyopathy.肝硬化性心肌病的病理生理学与临床研究方法
J Gastrointestin Liver Dis. 2014 Sep;23(3):301-10. doi: 10.15403/jgld.2014.1121.233.apac.
2
Cirrhotic cardiomyopathy: review of pathophysiology and treatment.肝硬化性心肌病:病理生理学与治疗综述
Hepatol Int. 2014 Jul;8(3):308-15. doi: 10.1007/s12072-014-9531-y.
3
Human serum albumin, systemic inflammation, and cirrhosis.人血清白蛋白、全身炎症与肝硬化。
Case Rep Gastroenterol. 2016 Oct 10;10(3):531-537. doi: 10.1159/000448885. eCollection 2016 Sep-Dec.
4
Hepatorenal syndrome: Update on diagnosis and treatment.肝肾综合征:诊断与治疗的最新进展
World J Nephrol. 2015 Nov 6;4(5):511-20. doi: 10.5527/wjn.v4.i5.511.
J Hepatol. 2014 Aug;61(2):396-407. doi: 10.1016/j.jhep.2014.04.012. Epub 2014 Apr 18.
4
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.肝硬化性心肌病:发病机制与临床相关性。
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):177-86. doi: 10.1038/nrgastro.2013.210. Epub 2013 Nov 12.
5
Interactions of the heart and the liver.心与肝的相互作用。
Eur Heart J. 2013 Sep;34(36):2804-11. doi: 10.1093/eurheartj/eht246. Epub 2013 Jul 12.
6
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Oct 15;128(16):e240-327. doi: 10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5.
7
New insights into cirrhotic cardiomyopathy.肝硬化性心肌病的新见解。
Int J Cardiol. 2013 Aug 20;167(4):1101-8. doi: 10.1016/j.ijcard.2012.09.089. Epub 2012 Oct 4.
8
Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis.多巴酚丁胺负荷超声心动图在评估肝硬化患者的肝硬化性心肌病中的应用
Korean J Hepatol. 2010 Dec;16(4):376-82. doi: 10.3350/kjhep.2010.16.4.376.
9
Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging.组织多普勒成像定量评估肝硬化患者的静息心肌功能障碍。
Liver Int. 2011 Apr;31(4):534-40. doi: 10.1111/j.1478-3231.2011.02468.x. Epub 2011 Feb 15.
10
Current treatment in acute and chronic cardio-renal syndrome.目前对急性和慢性心肾综合征的治疗。
Heart Fail Rev. 2011 Nov;16(6):583-94. doi: 10.1007/s10741-010-9202-6.